Predicting outcome by growth rate of locally recurrent retroperitoneal liposarcoma: The one centimeter per month rule
Continuity of Patient Care
Patient Care Bundles
Local recurrence growth rate is strongly associated with disease-specific survival and local control for patients with completely resected locally recurrent retroperitoneal liposarcoma. Despite aggressive operative management patients with a local recurrence growth rate greater than 0.9 cm/mo were associated with poor outcomes and should be considered for enrollment in clinical trials employing novel agents.